Fundraising Fox
MedEngine
Techstars '20Berlin, DE · Founded 2017 · 1 employees on LinkedIn · 1 known investors
Find your way into MedEngine
Sign up to see every warm intro you have to MedEngine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MedEngine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MedEngine builds a sensor wristwatch and companion Flytta app that continuously track motor and non-motor Parkinson's symptoms.
Also known as Flytta · MedEngine GmbH · MedEngine Health GmbH
Investors · 1
How we know: the Techstars portfolio · open dataset · Top 3000 Accelerator Startups (no YC) 2026-08 · Not right? Tell us
Company profile
researched Sep 2026MedEngine GmbH is a Berlin-based medical technology company developing a continuous monitoring system for Parkinson's disease. Its product combines a stainless steel wristwatch containing motion sensors and wireless connectivity with a mobile application called Flytta. The watch tracks motor symptoms of Parkinson's throughout the day and relays the data to the patient's smartphone, while the app captures non-motor symptoms and lifestyle factors including sleep, exercise, nutrition, medication and clinical assessments.
Patients can review a combined analysis of watch and app data in a simplified format to inform decisions about their care, and can share the data with doctors and therapists. The company frames the system as a way for clinicians to deliver more tailored care pathways in less time, noting that Parkinson's prevalence is expected to double over 20 years and that Europe has roughly one specialist per 500 patients. MedEngine Health GmbH, at Brunnenstrasse 141 A, 10115 Berlin, acts as data controller for the services, which comprise the Flytta app, the Flytta Watch and the flytta.info website; account data collected includes profile details, health insurance (optional), general health and medical condition data, and biometric data from the watch, processed under GDPR contract-performance and explicit-consent bases.
Founding story
Founders Christian Mellor and Philipp Brunnbauer met in London as lab partners and biomedical engineers at Imperial College. After identifying the potential for a low-cost medical device capable of continuously monitoring Parkinson's disease, they founded MedEngine GmbH in Berlin in 2017.
Business model
Startbase categorises the company as business-to-consumer with revenue from the sale of services. The offering consists of the Flytta mobile application, the Flytta Watch device and the flytta.info website, which users register for with a user account.
Traction
Startbase classified the company as seed stage with a team of 1-10 employees. The Flytta app was co-financed by the European Regional Development Fund (ERDF).
▸Full profile — market position, technology, go-to-market, geography, history
Market position
MedEngine addresses Parkinson's disease, described as the second most common neurodegenerative disease after Alzheimer's with no known cure, characterised by motor symptoms such as tremor, rigidity, bradykinesia and postural instability and non-motor symptoms including depression, sleep disorder, dementia and anxiety. The company positions its product against a shortage of specialists, citing approximately one specialist per 500 patients in Europe and an expected doubling of Parkinson's prevalence over the next 20 years.
Technology
The system pairs motion sensors and wireless connectivity embedded in a traditional-style stainless steel wristwatch with a smartphone application. The watch measures motor symptoms such as those associated with Parkinson's and transmits readings to the phone; the Flytta app records non-motor symptoms and lifestyle inputs such as sleep, exercise, nutrition, medication and clinical assessments. Collected data, including biometric data from the watch, is combined into an analysis presented to the patient and shareable with clinicians.
Go-to-market
People living with Parkinson's disease who track their motor and non-motor symptoms, along with the doctors and therapists with whom patients share their collected data.
Geography
Headquartered in Berlin, Germany, with the operating entity MedEngine Health GmbH registered at Brunnenstrasse 141 A, 10115 Berlin. The founders' collaboration originated in London at Imperial College.
History
The company was founded in Berlin in 2017 by Christian Mellor and Philipp Brunnbauer. Startbase records Brunnbauer as Geschäftsführer from 2017 to 2019 and lists him as an alumnus, with Christian Mellor listed as Geschäftsführer. As of the Startbase profile the company was at seed stage with 1-10 employees.
Compiled by commissioned research from 5 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsThe Flytta mobile application was co-financed by the European Regional Development Fund (ERDF).
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 5
primary sources listed
- Privacy Policy | MedEnginemedengine.co · web
5 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does MedEngine do?
- MedEngine builds a sensor wristwatch and companion Flytta app that continuously track motor and non-motor Parkinson's symptoms.
- Who are MedEngine's investors?
- MedEngine's investors include Techstars.
- Where is MedEngine headquartered?
- MedEngine is headquartered in Berlin, DE.